Polyunsaturated Fatty Acid Plasma Content in Groups of General Population with LowVitamin B6 or Low Iron Serum LevelsKrajčovičová-Kudláčková M. · Klvanová J. · Dušinská M.
Institute of Preventive and Clinical Medicine, Bratislava, Slovak Republic
Do you have an account?
- Rent for 48h to view
- Buy Cloud Access for unlimited viewing via different devices
- Synchronizing in the ReadCube Cloud
- Printing and saving restrictions apply
Rental: USD 8.50
Cloud: USD 20.00
Article / Publication Details
Experimental and human studies describe the adverse effect of iron or vitamin B6 deficiencies on polyunsaturated fatty acid metabolism. Iron is present in end proteins of the δ6-desaturase enzyme complex, and vitamin B6 deficiency can affect the transmethylation reaction of proteins. Plasma polyunsaturated fatty acid content was estimated in apparently healthy subjects of the general population with no consumption of fish and low vitamin B6 serum levels (<3 µg/l; n = 21) or with low iron serum levels (men: <12 µmol/l; women: <10 µmol/l; n = 16) and compared to a control group (n = 22) with normal vitamin B6 and iron serum levels (in reference range). The activities of the δ6-desaturase enzyme complex were calculated as product/precursor (conversion indices). In groups of subjects with low vitamin B6 and low iron levels, δ6-desaturase activity together with δ5-desaturase activity (conversion of α-linolenic/18:3,n–3/ into eicosapentaenoic acid/20:5,n–3/) as well as the conversion index of docosahexaenoic acid formation (22:6,n–3) from 22:5,n–3 (second δ6-desaturase activity) were significantly reduced. The inhibition effect on fatty acid synthesis was more pronounced in subjects with low iron levels than in those with low vitamin B6 levels. The conversion indices correlated significantly positively with vitamin B6 or iron levels.
© 2004 S. Karger AG, Basel
- Smuts CM, Tichelaar HY, van Jaarsveld PJ, Badenhorst CJ, Kruger M, Laubscher R, Mansvelt EP, Benade AJ: The effect of iron fortification on the fatty acid composition of plasma and erythrocyte membranes in primary school children with and without iron deficiency. Prostaglandins Leukot Essent Fatty Acids 1995;52:59–67.
- Cunnane SC, McAdoo KR: Iron intake influences essential fatty acid and lipid composition of rat plasma and erythrocytes. J Nutr 1987;117:1514–1519.
- Chen SCH, Dickerman S: Iron, thyroid hormone and essential fatty acid status of Honduran pre-schoolers. Nutr Res 1985;5:21–30.
Krajčovičová-Kudláčková M, Šimončič R, Béderová A, Klvanová J, Magálová T: Essential fatty acids and iron values in alternative nutrition groups. Cor Vasa 1998;40:285–289.
- Krajčovičová-Kudláčková M, Šimončič R, Béderová A, Klvanová J: Plasma fatty acid profile and alternative nutrition. Ann Nutr Metab 1997;41:365–370.
- Rao GA, Larkin EC: Role of dietary iron in lipid metabolism. Nutr Res 1984;4:145–151.
- Okayasu T, Nagano M, Ishibashi T, Imai Y: Purification and partial characterization of linoleyl CoA desaturase from rat liver microsomes. Arch Biochem Biophys 1981;206:21–42.
- Bordoni A, Hrelia S, Lorenzini A, Bergani R, Cabrini L, Biagi PL, Tolomelli B: Dual influence of aging and vitamin B6 deficiency on delta6-desaturation of essential fatty acids in rat liver microsomes. Prostaglandins Leukot Essent Fatty Acids 1998;58:417–420.
Tsuge H, Hotta N, Hayakawa T: Effect of vitamin B6 on n–3 polyunsaturated fatty acid metabolism. J Nutr 2000;130:333–334.
- She QB, Hayakawa T, Tsuge H: Alteration of the phosphatidylcholine biosynthesis of rat liver microsomes caused by vitamin B6 deficiency. Biosci Biotechnol Biochem 1995;59:163–167.
- Nguyen TT, Hayakawa T, Tsuge H: Effect of vitamin B6 deficiency on the synthesis and accumulation of S-adenosylhomocysteine and adenosylmethionine in rat tissues. J Nutr Sci Vitaminol 2001;47:188–194.
- Koba K, Wakamatsu K, Obata K, Sugano M: Effect of dietary proteins on linoleic acid desaturation and membrane fluidity in rat liver microsomes. Lipids 1993;28:457–464.
- Lapage G, Roy CC: Direct transesterification of all classes of lipids in one step reaction. J Lipid Res 1986;27:114–120.
- Brenner RR: Regulatory function of delta6-desaturase key enzymes of polyunsaturated fatty acid synthesis. Adv Exp Med Biol 1977;83:85–101.
- Antueno RJ, Knickle LC, Smith H, Elliot ML, Allen SJ, Nwaka S, Winther MD: Activity of human delta5- and delta6-desaturases on multiple n–3 and n–6 polyunsaturated fatty acids. FEBS Lett 2001;509:77–80.
- Marzo I, Alava MA, Pineiro A, Naval J: Biosynthesis of docosahexaenoic acid in human cells, evidence that two different delta6-desaturase activities may exist. Biochim Biophys Acta 1996;1301:263–272.
- Brenner RR: The oxidative desaturation of unsaturated fatty acids in animals. Mol Cell Biochem 1974;3:41–52.
Vojtaššáková A, Kováčiková E, Simonová E, Holčíková K, Pastorová J, Klvanová J: Fats, oil bearing plants, oils and nuts. Bratislava, Food Research Institute, 2000, 41–64.
- Jiang Z, Sim JS: Consumption of n–3 polyunsaturated fatty acid-enriched eggs and changes in plasma lipids of human subjects. Nutrition 1993;9:513–518.
- Béderová A, Krajčovičová-Kudláčková M, Klvanová J, Magálová T, Brtková A, Barteková S: Plasma essential fatty acids and iron in children on vegetarian and mixed diets. Klin Biochem Metab 1999;7:108–112.
Article / Publication Details
Copyright / Drug Dosage / DisclaimerCopyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.